Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Roivant Sciences to acquire Silicon Therapeutics to boost drug discovery capabilities Roivant Sciences has agreed to acquire Silicon Therapeutics, a Boston-based drug design, research, and development company, for $450… bySrinathFebruary 26, 2021
